KSM Feed

Our Deputy Head Dr. Sivan Gazit on Channel 13 evening news.

82% decreased risk of reinfection among persons who were infected and then vaccinated.

Association of BNT162b2 COVID-19 Vaccination During Pregnancy With Neonatal and Early Infant Outcomes.

Waning of SARS-CoV-2 booster viral-load reduction effectiveness.

Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine.

Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two and Three doses of Vaccine.

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections.

Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two and Three doses of Vaccine.

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections.

Our new study on COVID-19 vaccine effectiveness in patients with Inflammatory Bowel Disease (IBD).

Continuing to monitor vaccinated members – 62 days following the first vaccine dose.

Continuing to monitor vaccinated members. Coronavirus update February 18.

Our study assessing the correlation between time-from-vaccine and incidence of breakthrough infection.

The safety and effectiveness of the COVID-19 vaccine on pregnant population.

Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals.